Asia Pacific Generic Injectables Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Large Molecule Injectables and Small Molecule Injectables), Container Type (Vials, Premix, Prefilled Syringes, Ampoules, and Others), Application (Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology, and Others), and Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others) 

No. of Pages: 167    |    Report Code: BMIRE00024995    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Generic Injectables Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Generic injectables Market – By Product Type

1.3.2        APAC Generic injectables Market – By Container Type

1.3.3        APAC Generic injectables Market – By Application

1.3.4        APAC Generic injectables Market – By Route of Administration

1.3.5        APAC Generic injectables Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Generic Injectables Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        APAC PEST Analysis

4.3         Experts Opinion

5.           APAC Generic Injectables Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Low R&D, Marketing, and Manufacturing Costs

5.1.2        High Demand for Affordable Drugs

5.2         Market Restraints

5.2.1        Critical Inspection System for Prefilled Injection

5.3         Market Opportunities

5.3.1        Increasing Patent Expiry of Drugs

5.4         Future Trends

5.4.1        Government Support for Generic Injectables Production and Healthcare Cost Reduction

5.5         Impact Analysis

6.           Generic Injectables Market– APAC Analysis

6.1         APAC Generic Injectables Market Revenue Forecast and Analysis

7.           APAC Generic Injectables Market– by Product Type

7.1         Overview

7.2         APAC Generic Injectables Market, By Product Type, 2021 & 2028 (%)

7.3         Large Molecule Injectables

7.3.1        Overview

7.3.2        Large Molecule Injectables: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

7.4         Small Molecule Injectables

7.4.1        Overview

7.4.2        Small Molecule Injectables: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.           APAC Generic Injectables Market– by Container Type

8.1         Overview

8.2         APAC Generic Injectables Market, By Container Type, 2021 & 2028 (%)

8.3         Vials

8.3.1        Overview

8.3.2        Vials: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.4         Premix

8.4.1        Overview

8.4.2        Premix: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.5         Prefilled Syringes

8.5.1        Overview

8.5.2        Prefilled Syringes: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.6         Ampoules

8.6.1        Overview

8.6.2        Ampoules: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.           APAC Generic Injectables Market– by Application

9.1         Overview

9.2         APAC Generic Injectables Market, By Application, 2021 & 2028 (%)

9.3         Oncology

9.3.1        Overview

9.3.2        Oncology: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.4         Infectious Diseases

9.4.1        Overview

9.4.2        Infectious Diseases: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.5         Cardiology

9.5.1        Overview

9.5.2        Cardiology: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.6         Diabetes

9.6.1        Overview

9.6.2        Diabetes: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.7         Immunology

9.7.1        Overview

9.7.2        Immunology: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.8         Others

9.8.1        Overview

9.8.2        Others: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.        APAC Generic Injectables Market– by Route of Administration

10.1      Overview

10.2      APAC Generic Injectables Market, By Route of Administration, 2021 & 2028 (%)

10.3      Intravenous

10.3.1     Overview

10.3.2     Intravenous: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.4      Intramuscular

10.4.1     Overview

10.4.2     Intramuscular: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.5      Subcutaneous

10.5.1     Overview

10.5.2     Subcutaneous: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.6      Others

10.6.1     Overview

10.6.2     Others: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

11.        APAC Generic Injectables Market– Country Analysis

11.1      APAC: Generic Injectables Market

11.1.1     Overview

11.1.3     APAC: Generic Injectables Market, by Country, 2021 & 2028 (%)

11.1.3.1       China: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.1.1       China: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.1.2       China: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.3.1.3       China: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.3.1.4       China: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.3.1.5       China: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.3.2       Japan: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.2.1       Japan: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.2.2       Japan: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.3.2.3       Japan: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.3.2.4       Japan: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.3.2.5       Japan: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.3.3       India: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.3.1       India: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.3.2       India: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.3.3.3       India: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.3.3.4       India: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.3.3.5       India: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.3.4       Australia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.4.1       Australia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.4.2       Australia: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.3.4.3       Australia: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.3.4.4       Australia: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.3.4.5       Australia: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.3.5       South Korea: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.5.1       South Korea: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.5.2       South Korea: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.3.5.3       South Korea: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.3.5.4       South Korea: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.3.5.5       South Korea: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.3.6       Rest of APAC: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.6.1       Rest of APAC: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.6.2       Rest of APAC: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.3.6.3       Rest of APAC: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.3.6.4       Rest of APAC: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.3.6.5       Rest of APAC: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

12.        APAC Generic Injectables Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      AstraZeneca

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Baxter International Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Biocon

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Fresenius SE & Co. KGaA

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      GlaxoSmithKline plc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Johnson and Johnson Services, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Lupin

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Viatris Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Merck & Co., Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Pfizer Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             APAC Generic injectables Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             China Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             China Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 4.             China Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 5.             China Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 6.             Japan Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             Japan Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Japan Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 9.             Japan Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 10.          India Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          India Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          India Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13.          India Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.          Australia Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Australia Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 16.          Australia Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 17.          Australia Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 18.          South Korea Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 19.          South Korea Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 20.          South Korea Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 21.          South Korea Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of APAC Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of APAC Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of APAC Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of APAC Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 26.          Organic Developments Done By Companies

Table 27.          Inorganic Developments Done By Companies

Table 28.          Glossary of Terms, APAC Generic Injectables Market

 


LIST OF FIGURES

Figure 1.           APAC Generic injectables Market Segmentation

Figure 2.           APAC Generic injectables Market, By Country

Figure 3.           APAC Generic Injectables Market Overview

Figure 4.           Large Molecule Injectable Segment Held Largest Share of Product Type Segment in APAC Generic injectables Market

Figure 5.           India is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           APAC: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           APAC Generic injectables Market Impact Analysis of Driver and Restraints

Figure 9.           APAC Generic injectables Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        APAC Generic Injectables Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Large Molecule Injectables: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Small Molecule Injectables: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        APAC Generic Injectables Market, by Container Type, 2021 & 2028 (%)

Figure 14.        Vials: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Premix: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Prefilled Syringes: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Ampoules: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Others: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        APAC Generic Injectables Market, by Application, 2021 & 2028 (%)

Figure 20.        Oncology: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Infectious Diseases: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Cardiology: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diabetes: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Immunology: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Others: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        APAC Generic Injectables Market, by Route of Administration, 2021 & 2028 (%)

Figure 27.        Intravenous: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Intramuscular: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Subcutaneous: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Others: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 31.        APAC: Generic Injectables Market, by Key Country – Revenue (2021) (USD Million)

Figure 32.        China: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Japan: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        India: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        Australia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        South Korea: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.        Rest of APAC: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

The List of Companies - Asia Pacific Generic Injectables Market

  1. AstraZeneca
  2. Baxter International Inc.
  3. Biocon
  4. Fresenius SE & Co. KGaA
  5. GlaxoSmithKline plc
  6. Johnson and Johnson Services, Inc.
  7. Lupin
  8. Merck & Co., Inc.
  9. Pfizer Inc.
  10. Viatris Inc